Entresto 97 MG-103 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FHXWC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,232
Award facts
- Contract value 100% obligated
- $79,231.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count) under a firm fixed-price contract valued at $79,231.93, with completion targeted for September 9, 2025. This non-set-aside award represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
Entresto is a combination cardiovascular medication primarily used for heart failure treatment, reflecting the scope of branded pharmaceutical products procured by DLA to support military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor within the federal medical supply chain, delivering a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract demonstrates the company's capacity to fulfill substantial federal pharmaceutical procurement requirements on a global basis in support of Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FHXWC?
SPE2DB25FHXWC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FHXWC worth?
The government has obligated $79,232 on SPE2DB25FHXWC.
Is contract SPE2DB25FHXWC an order under another contract?
Yes. SPE2DB25FHXWC is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB25FHXWC competed?
The extent of competition for SPE2DB25FHXWC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award